Domov › CHOPN › Alabama › Birmingham
Klinické štúdie CHOPN v meste Birmingham, AL
17 štúdií pre CHOPN hľadá účastníkov v zariadeniach v meste Birmingham a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Prebieha náborFáza 3
- University of Alabama at Birmingham- Site Number : 8400003, Birmingham
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Prebieha náborFáza 2
- University of Alabama at Birmingham, Birmingham
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
Prebieha náborFáza 4
- University of Alabama at Birmingham - School of Medicine- Site Number : 8400003, Birmingham
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Prebieha náborFáza 2
- Research Site, Birmingham
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Prebieha náborFáza 2
- University of Alabama, Birmingham
A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
Prebieha náborFáza 1
- University of Alabama at Birmingham, Birmingham
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Prebieha náborFáza 2/3
- University of Alabama at Birmingham Lung Health Center, Birmingham
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
Prebieha náborFáza 3
- GC2501 Study Site 106, Birmingham
Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities
Prebieha náborObservačná štúdia
- Cooper Green Mercy Hospital, Birmingham
Multi-Center Clean Air Randomized Controlled Trial in COPD
Prebieha náborFáza 3
- University of Alabama, Lung Health Center, Birmingham
Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
Prebieha nábor
- The University of Alabama at Birmingham, Birmingham
SPIROMICS Study of Early COPD Progression (SOURCE)
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- University of Alabama at Birmingham, Birmingham
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
Prebieha nábor
- University of Alabama-Birmingham Hospital - UAB Lung Health Center, Birmingham
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
Prebieha nábor
- University of Alabama at Birmingham, Birmingham
PiMZ Longitudinal Cohort (PiMZ Logic)
Prebieha náborObservačná štúdia
- University of Alabama at Birmingham, Birmingham
Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency
Prebieha náborFáza 4
- University of Alabama at Birmingham, Birmingham
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
Prebieha nábor
- UAB School of Medicine/Lung Health Center, Birmingham
Štúdie CHOPN v iných mestách
- Philadelphia, PA23 štúdií
- Miami, FL18 štúdií
- Boston, MA17 štúdií
- Houston, TX15 štúdií
- Orlando, FL15 štúdií
- Baltimore, MD14 štúdií
- Chicago, IL14 štúdií
- Dallas, TX12 štúdií
- Pittsburgh, PA12 štúdií
- New York City, NY11 štúdií
- Ann Arbor, MI10 štúdií
- Winston-Salem, NC9 štúdií
Iné štúdie v Birmingham
- Rakovina (všetky typy)30 štúdií
- Rakovina prsníka24 štúdií
- Obézita23 štúdií
- Rakovina vaječníkov23 štúdií
- Nemalobunkový karcinóm pľúc22 štúdií
- Akútna myeloidná leukémia21 štúdií
- Mnohonásobný myelóm18 štúdií
- Kardiovaskulárne ochorenia17 štúdií
- Nadváha16 štúdií
- Rakovina endometria16 štúdií
- Diabetes mellitus 2. typu16 štúdií
- Cystická fibróza16 štúdií
Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.